INTRODUCTION AND OBJECTIVES:
Communities of microorganisms that inhabit the human body and are important regulators of the immune system and metabolism are known as a microbiome. The urinary microbiome has been difficult to study due to low bacterial burden and invasiveness of sampling, particularly in the upper tract. It thus remains unclear how it contributes to homeostasis or disease. In this study, we utilize 16S sequencing confirm and characterize the existence of a microbiome in both the upper and lower urinary tract in patients with nephrolithiasis.
METHODS: During endoscopic procedures (5 ureteroscopic, 1 percutaneous nephrolithotomy) for stone removal, we collected specimens from both upper and lower urinary tracts (bladder urine, kidney urine, brush and cup biopsies of renal papilla, and stone fragments) for microbiome analysis. Patients with any history of antibiotic or steroid exposure within six months preceding surgery were excluded. After DNA extraction and PCR amplification, microbiome identification was expressed in operation taxonomic units (OTUs) using 16S ribosomal RNA sequencing from Illumina NextSeq (Illumina, Inc., CA) targeted at the V4 hypervariable region. Paired sequencing reads were quality filtered and demultiplexed using the USEARCH and QIIME software packages before being assembled and further processed. Assembled sequencing read pairs were binned into OTUs using a 97% sequence similarity to a database of known sequences.
RESULTS: Six adult patients with mean age 55.8AE14.4 years and BMI of 29.3AE3.6 kg/m2 undergoing endoscopic stone surgery at our institution were enrolled. Thirty of 33 specimens demonstrated DNA quality above threshold for analysis. A microbiome consisting primarily of proteobacteria, firmicutes, bacteroides, and actinobacteria was demonstrated in both upper and lower urinary tract of the affected kidney in each nephrolithiasis patient. Diversity indices were not significantly different between the upper tract specimens and bladder urine. Two patients with uric acid stones demonstrated enrichment of proteobacteria in their stone specimens which was not observed in the other specimens from these two patients.
CONCLUSIONS: This study confirms the presence of microbial communities in both upper and lower urinary tracts of nephrolithiasis patients with no significant differences between the two. Here we establish a reliable methodology to perform microbiome analysis on the entire urinary tract. Larger scale studies are ongoing to validate these findings and verify how the microbiome plays a role in stone formation and urinary tract infection. 
MP24-10 WAVELENGTH AND PULSE SHAPE EFFECTS ON STONE FRAGMENTATION OF LASER LITHOTRIPTERS
Andreas Gross*, Benedikt Becker, Hamburg, Germany; Mark Taratkin, Dmitry Enikeev, Leonid Rapoport, Moscow, Russian Federation; Christopher Netsch, Hamburg, Germany INTRODUCTION AND OBJECTIVES: Pulsed Holmium:YAG lasers are the energy source of choice in the endoscopic management of urolithiasis. Until recently, pulse frequency and pulse energy were the most investigated parameters to improve efficiency of such lasers. Newer research focusses on the influence of pulse width and pulse shape. Aim of our study was to compare the efficiency of stone dusting of pulsed 2.1mm Holmium:YAG lasers and a pulsed 1.94mm Thuliumfiber laser (TFL) using identical pulse energy, pulse frequency, and average power settings.
METHODS: The lasers systems tested were the Lumenis Versa Pulse Power Suite P 100 (Ho short pulse), the Lumenis Pulse 120H (Ho long pulse) and a commercially not available prototype of a pulsed TFL (Fig.1, A) to C) ). The lasers were tested at 0.2 J and 40 Hz (average power of 8-W). Pulse energies and pulse shapes were measured. Subsequently, efficiency of stone ablation (ablation speed) was compared in vitro on human COM, COM-phosphate, and Uric Acid stones for the three lasers. The in vitro experimental setup included a specially designed cuvette with several levels of metallic meshes allowing for precise quantification of size distribution of stone fragments.
RESULTS: The pulsewidths (range in ms) of all three lasers are shown in Fig. 1 below. The following values of the peak power were derived from the pulse shape and pulse energy measurements: P100: 1650-W, P120: 1040-W, TFL: 660-W. The measured values of stone ablation speed (in dusting mode, i.e. fragments < 1mm) are summarized in Fig.2 .
CONCLUSIONS: The new pulsed TFL shows a clearly defined pulsewidth with a large area under the curve. This in combination with the wavelength superior in terms of water absorption leads to better efficiency of stone fragmentation in dusting mode. Vol. 199, No. 4S, Supplement, Friday, May 18, 2018 THE JOURNAL OF UROLOGY â e293
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MP24-11 LONG-TERM TREATMENT OF VITAMIN D INSUFFICIENCY OR DEFICIENCY IN POSTMENOPAUSAL WOMEN WITH HYPERCALCIURIA DOES NOT INCREASE URINARY CALCIUM EXCRETION
Kristina L. Penniston*, Karen E. Hansen, Abigail C. Staples, Stephen Y. Nakada, R. Allan Jhagroo, Madison, WI INTRODUCTION AND OBJECTIVES: Vitamin D (VD) repletion in calcium (Ca) stone formers is sometimes questioned, especially if long-term and/or in those with hypercalciuria (>250 mg/d). We assessed the effect of VD repletion for 1 year on urinary Ca excretion.
METHODS: The study was randomized, double-blind, placebocontrolled, and IRB-approved. Postmenopausal women with low VD status [serum 25(OH)D <30 ng/mL; n¼90; 61AE6 y; BMI 30.8AE6.8) were randomized to placebo, low-dose (LD) VD (800 IU daily), or high-dose (HD) VD (50,000 IU for 15 d followed by 50,000 IU twice/month for 1 y). Prefilled 31-day pill boxes were dispensed; remaining capsules were counted at study visits (60, 120, & 365 days) to assess compliance. Multiple-day weighed diet records prior to intervention were completed by all to establish individuals 0 usual nutritional intake. To reduce dietary confounders in 24-h urine collections, dietary intake was reproduced for energy and nutrient composition for each participant during her baseline and 1 y visits, during which 24-h urine collections were collected.
RESULTS: Median baseline urinary Ca excretion was 209 mg/ d. Compliance with treatment was estimated at approximately 100% across all arms. Overall, urinary Ca excretion was unchanged at 1 y (228AE70 to 219AE92 mg/d; P¼0.25, paired t-test). Only women in the HD group achieved 25(OH)D !30 ng/mL (21AE3 to 56AE12 ng/mL; P<0.001). Despite this rise in VD status, urinary Ca excretion did not increase in this group (256AE86 to 250AE131 mg/d; P¼0.74). Nor did urinary Ca excretion change in the other groups (P!0.27 for withingroup pairwise comparisons from baseline to 1 y). Among hypercalciuric women across all groups (figure; n¼28), Ca excretion did not change (312AE60 to 273AE130 mg/d; P¼0.07), but tended to be lower. Hypercalciuria was resolved at 1 y in 40%, 57%, and 50% in HD, LD, and placebo groups, respectively. The incidence of new hypercalciuria at 1 y was 6.7%, 19%, and 12%, respectively. CONCLUSIONS: Despite a significant rise in VD status, VD repletion at 50,000 IU twice monthly for 1 y, following a loading dose, did not increase urinary Ca excretion in postmenopausal women with or without hypercalciuria. VD repletion at lower doses also did not increase urinary Ca, and goal VD status was not achieved. Evidence suggests the risk for hypercalciuria is low following VD repletion in patients with low VD status.
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